Avacta Group (LON:AVCT) Shares Cross Below 200 Day Moving Average – Time to Sell?

Avacta Group Plc (LON:AVCT)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 64.69 and traded as low as GBX 63. Avacta Group shares last traded at GBX 65, with a volume of 7,330,272 shares trading hands.

Avacta Group Trading Down 3.8%

The firm has a fifty day simple moving average of GBX 61.61 and a 200-day simple moving average of GBX 64.76. The company has a debt-to-equity ratio of 14,168.75, a current ratio of 0.79 and a quick ratio of 4.96. The firm has a market cap of £284.46 million, a P/E ratio of -3.70 and a beta of 1.12.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).